Recently Visited
{{scheme.stockprice}}
{{scheme.chgp}}%
{{scheme.chgp}}%
{{scheme.scoreText}} |
Score {{scheme.score}}
{{scheme.score}}
{{scheme.scoretext}}
{{ scheme.tag }}
Most Searched
{{scheme.stockprice}}
{{scheme.chgp}}%
{{scheme.chgp}}%
{{scheme.scoreText}} |
Score {{scheme.score}}
{{scheme.score}}
{{scheme.scoretext}}
{{ scheme.tag }}
No Matches Found
Search results for {{searchTermHome}}
{{scheme.stockprice}}
{{scheme.chgp}}%
{{scheme.chgp}}%
{{scheme.scoreText}} | Score
{{scheme.score}}
{{scheme.score}}
{{scheme.scoretext}}
{{ scheme.tag }}
No Matches Found
No Matches Found
Iterum Therapeutics Plc
Is Iterum Therapeutics Plc overvalued or undervalued?
Loading...
Is Iterum Therapeutics Plc technically bullish or bearish?
As of October 1, 2023, there is insufficient technical data for Iterum Therapeutics Plc to determine a bullish or bearish outlook.
Who are in the management team of Iterum Therapeutics Plc?
As of March 2022, Iterum Therapeutics Plc's management team includes CEO Corey Fishman, Independent Interim Chairman Brenton Ahrens, and several independent directors: Michael Dunne, Mark Chin, Patrick Heron, Ronald Hunt, and David Kelly.
What does Iterum Therapeutics Plc do?
Iterum Therapeutics Plc is a clinical-stage pharmaceutical company focused on developing anti-infectives for multi-drug resistant pathogens. It has a market cap of $39.20 million and reported a net profit loss of $5 million as of March 2025.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
![]( "Upgrade & View All Insights")
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read